Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes

Diabetes Research and Clinical Practice

Volumn 94, Issue 3, 2011, Pages 426-433

  Ozuguz, Ufuk ^a   Isik, Serhat ^a   Berker, Dilek ^a   Arduc, Ayse ^a   Tutuncu, Yasemin ^a   Akbaba, Gulhan ^a   Gokay, Ferhat ^a   Guler, Serdar ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gestational diabetes; Subclinic inflammation; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CAROTID ARTERY INTIMA MEDIA THICKNESS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGESTATIONAL BODY MASS INDEX; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PUERPERIUM; RISK FACTOR; SUBCLINICAL INFLAMMATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADULT; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN RESISTANCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TUNICA INTIMA;

EID: 82955193334     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.08.024     Document Type: Article

References (41)

1. American Diabetes Association Gestational diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):103-105.
2. O'Sullivan J.B. Diabetes mellitus after GDM. Diabetes 1991, 40(Suppl. 2):131-135.
3. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
4. Carpenter M.W., Coustan D.R. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982, 144:768-773.
5. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
6. Ford E.S. Body mass index, diabetes, and C-reactive protein among US adults. Diabetes Care 1999, 22:1971-1977.
7. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
8. Tsigos C., Papanicolaou D.A., Kyrou I., Defensor R., Mitsiadis C.S., Chrousos G.P. Dose dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997, 82:4167-4170.
9. Stith R.D., Luo J. Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 1994, 44:210-215.
10. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 2000, 58:1703-1710.
11. Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-51.
12. Cao J.J., Arnold A.M., Manolio T.A., Polak J.F., Psaty B.M., Hirsch C.H., et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007, 116:32-38.
13. Wang T.J., Nam B.H., Wilson P.W., Wolf P.A., Levy D., Polak J.F., et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002, 22:1662-1667.
14. Kivimäki M., Lawlor D.A., Juonala M. Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2005, 25:2197-2202.
15. Tremblay A.J., Morrissette H., Gagné J.M., Bergeron J., Gagné C., Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004, 37(9):785-790.
16. Howard G., Sharrett A.R., Heiss G., Evans G.W., Chambless L.E., Riley W.A., et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound ARIC Investigators. Stroke 1993, 24:1297-1304.
17. Buchanan T.A., Kjos S.L. Gestational diabetes: risk or myth?. J Clin Endocrinol Metab 1999, 84:1854-1857.
18. Catalano P.M., Huston L., Amini S.B., Kalhan S.C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999, 180:903-916.
19. Metzger B.E., Cho N.H., Roston S.M., Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993, 16:1598-1605.
20. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999, 353:1649-1652.
21. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
22. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:745-751.
23. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. West of Scotland Coronary Prevention Study C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002, 51:1596-1600.
24. Barzilay J.I., Abraham L., Heckbert S.R., Cushman M., Kuller L.H., Resnick H.E., et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001, 50:2384-2389.
25. Festa A., D'Agostino R., Tracy R.P., Haffner S.M. Insulin Resistance Atherosclerosis Study elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 51:1131-1137.
26. Wolf M., Sandler L., Hsu K., Vossen-Smirnakis K., Ecker J.L., Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003, 26:819-824.
27. Retnakaran R., Hanley A.J., Raif N., Connelly P.W., Sermer M., Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003, 88:3507-3512.
28. Di Benedetto A., Russo G.T., Corrado F., Di Cesare E., Alessi E., Nicocia G., et al. Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest 2005, 28(1):34-38.
29. Di Cianni G., Lencioni C., Volpe L., Ghio A., Cuccuru I., Pellegrini G., et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007, 23(2):135-140.
30. Winzer C., Wagner O., Festa A., Schneider B., Roden M., Bancher-Todesca D., et al. Plasma adiponectin: insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004, 27(7):1721-1727.
31. Di Cianni G., Miccoli R., Volpe L., Lencioni C., Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003, 19:259-270.
32. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999, 19:972-978.
33. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
34. Magyar M.T., Szikszai Z., Balla J., Valikovics A., Kappelmayer J., Imre S., et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003, 34:58-63.
35. Winbeck K., Kukla C., Poppert H., Klingelhöfer J., Conrad B., Sander D. Elevated Creactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002, 13:57-63.
36. Tarim E., Yigit F., Kilicdag E., Bagis T., Demircan S., Simsek E., et al. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2006, 27:177-182.
37. Brownlee M. Lilly Lecture 1993 Glycation and diabetic complications. Diabetes 1994, 43:836-841.
38. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
39. Williams S.B., Goldfine A.B., Timimi F.K., Ting H.H., Roddy M.A., Simonson D.C., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998, 97:1695-1701.
40. Mügge A., Elwell J.H., Peterson T.E., Harrison D.G. Release of intact endothelium derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 1991, 260:219-225.
41. Rubanyi G.M., Vanhoutte P.M. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986, 250:815-821.